NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDLenvatinib Lenvima®, Kisplyx®
(4mg, 10mg capsules) 		Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Lenvatinib Lenvatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA498: Lenvatinib with everolimus for previously treated advanced renal cell carcinoma
NICE TA535: Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine
NICE TA551: Lenvatinib for untreated advanced hepatocellular carcinoma
NICE TA858 Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma
NICE TA858: Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma
NICE TA904: Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer